medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2024, Number 10

<< Back Next >>

Med Int Mex 2024; 40 (10)

Rational use of vancomycin and the problem of bacterial resistance

Vargas RLJ, García AL
Full text How to cite this article

Language: Spanish
References: 10
Page: 702-703
PDF size: 291.69 Kb.


Key words:

No keywords

Text Extraction

No abstract.


REFERENCES

  1. Kumar M, Sarma DK, Shubham S, Kumawat M, et al.Futuristic non-antibiotic therapies to combat antibioticresistance: A review. Front Microbiol 2021; 12: 609459.

  2. Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS.Antimicrobial resistance. JAMA 2016; 316 (11): 1193. doi:10.1001/jama.2016.11764

  3. Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobialresistance in developing countries: causes andcontrol strategies. Antimicrob Resist Infect Control 2017;6 (1): 47. https://doi.org/10.1186/s13756-017-0208-x

  4. Elmahi OKO, Musa RAE, Shareef AAH, Omer MEA, et al.Perception and practice of self-medication with antibioticsamong medical students in Sudanese universities: Across-sectional study. PLoS One 2022; 17 (1): e0263067.doi: 10.1371/journal.pone.0263067

  5. Yu W, Zhang J, Tong J, Zhang L, et al. In vitro antimicrobialactivity of fosfomycin, vancomycin and daptomycin alone,and in combination, against linezolid-resistant Enterococcusfaecalis. Infect Dis Ther 2020; 9 (4): 927-934. https://doi.org/10.1007/s40121-020-00342-1

  6. Hua Xiao Zhou, Xin Chen, Lijuan Shen, Shuping Cai, HongJian Ji. Rational application of vancomycin in patients withvarious pathological conditions. Eur J Hosp Pharm 2020; 27(2): 127. doi: 10.1136/ejhpharm-2019-002077

  7. Sultan I, Rahman S, Jan AT, Siddiqui MT, et al. Antibiotics,resistome and resistance mechanisms: A bacterialperspective. Front Microbiol 2018; 9: 2066. doi: 10.3389/fmicb.2018.02066

  8. Nardulli P, Hall GG, Quarta A, Fruscio G, et al. Antibioticabuse and antimicrobial resistance in hospital environment:A retrospective observational comparative study. Medicina2022; 58: 1257. https://doi.org/10.3390/medicina58091257

  9. Kollef MH, Fraser VJ. Antibiotic resistance in the intensivecare unit. Ann Intern Med 2001; 134: 298-314. doi:

  10. 10.7326/0003-4819-134-4-200102200-0001410. Atif M, Zia R, Malik I, Ahmad N, Sarwar S. Treatment outcomes,antibiotic use and its resistance pattern amongneonatal sepsis patients attending Bahawal Victoria Hospital,Pakistan. PLoS ONE 2021; 16 (1): e0244866. https://doi.org/10.1371/journal.pone.0244866




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2024;40